This inventor holds 16 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Novartis Ag, Novartis Pharma Ag. Active years: 2012-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oberswil, CH (2015)
- Oberwil, CH (2012 - 2024)
Company Filing History:
Years Active: 2012-2024
Title: The Innovative Contributions of Christoph Heusser
Introduction
Christoph Heusser, an accomplished inventor based in Oberwil, Switzerland, has made significant strides in the field of biopharmaceuticals. With a total of 16 patents to his name, Heusser's work focuses on developing innovative solutions for medical challenges, particularly in the realm of antibody formulations and transplant rejection treatments.
Latest Patents
Among his latest innovations are the "Anti-BAFFR antibody formulations and methods of use thereof," which detail the formulation of anti-BAFFR antibodies as either lyophilisates or liquid compositions. These formulations are designed to be reconstituted, yielding solutions with high concentrations of the antibody active ingredient—at least 50 mg/ml. This advancement allows for efficient delivery of the medication to patients with minimal antibody aggregation. Furthermore, Heusser has patented a "Method of treating transplant rejection with silent Fc variants of anti-CD40 antibodies." This invention involves the use of silent Fc variants of anti-CD40 antibodies, providing a new approach for treating autoimmune disorders and preventing graft rejection in transplantation procedures.
Career Highlights
Heusser's career has been marked by his tenure at renowned pharmaceutical companies such as Novartis AG and Novartis Pharma AG. His extensive experience within these organizations has allowed him to develop and refine his innovative ideas, leading to breakthroughs that enhance therapeutic options for patients.
Collaborations
Throughout his career, Christoph Heusser has collaborated with esteemed colleagues, including James Rush and Karen Vincent. These partnerships have fostered a productive environment for innovation, leveraging shared expertise to advance the field of biotechnology.
Conclusion
In summary, Christoph Heusser stands out as a prominent inventor in the biopharmaceutical sector. His contributions, particularly in antibody formulations and transplant rejection treatments, have significant implications for patient care and medical science. With 16 patents to his name and a history of collaboration with leading professionals, Heusser's work continues to shape the future of medical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile